In order to further clarify the relationship between MEKi treatment and PD-L1/MHC-I expression, we need to first determine whether this relationship is conserved in additional breast cancer models, and second, further examine the mechanism by which MEKi treatment induces immune-associated protein expression. The gene discussed is CD274; the disease is breast cancer.